Literature DB >> 27651720

Factors affecting clinical pregnancy rates after IUI for the treatment of unexplained infertility and mild male subfertility.

Melahat Atasever1, Müberra Namlı Kalem2, Şafak Hatırnaz3, Ebru Hatırnaz3, Ziya Kalem4, Zeynep Kalaylıoğlu5.   

Abstract

OBJECTIVE: The aim of the present retrospective study was to evaluate intrauterine insemination (IUI) clinical experiences and to define the variables for predicting success.
MATERIAL AND METHODS: The present study was an observational trial performed in a private IVF center on subfertile couples who had applied for treatment between 2002 and 2012, in which the data of 503 IUI cases were retrospectively reviewed. Couples who had been diagnosed with unexplained and mild male subfertility were included. The primary outcome measure was the clinical pregnancy rate in an attempt to form a predictive model for the odds of a clinical pregnancy. Recorded parameters were used to determine the prediction model.
RESULTS: Utilizing univariate logistic regression analysis, clinical pregnancy was positively associated with the duration of infertility (OR=1.09, p=0.089), secondary infertility (OR=1.77, p=0.050), and +4 sperm motility after preparation (OR=1.03, p=0.091). Following an adjustment analysis involving a multivariate logistic regression, clinical pregnancy was still found to positively associate with secondary infertility (OR=2.51, p=0.008).
CONCLUSION: IUI success in secondary infertile couples who were in the unexplained infertility and mild male subfertility groups was higher than that in primary infertile couples, and the chances of pregnancy increased as sperm numbers with +4 motility increased. It is difficult to concomitantly evaluate all these parameters and to determine a predictive parameter in IUI independent from other factors.

Entities:  

Keywords:  Intrauterine insemination; male subfertility; unexplained infertility

Year:  2016        PMID: 27651720      PMCID: PMC5019828          DOI: 10.5152/jtgga.2016.16056

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  37 in total

Review 1.  The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis.

Authors:  M M E van Rumste; I M Custers; F van der Veen; M van Wely; J L H Evers; B W J Mol
Journal:  Hum Reprod Update       Date:  2008-08-06       Impact factor: 15.610

2.  Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial.

Authors:  Felice Francavilla; Filomena Sciarretta; Sara Sorgentone; Stefano Necozione; Riccardo Santucci; Arcangelo Barbonetti; Sandro Francavilla
Journal:  Fertil Steril       Date:  2009-03-03       Impact factor: 7.329

3.  Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success.

Authors:  M J Tomlinson; J B Amissah-Arthur; K A Thompson; J L Kasraie; B Bentick
Journal:  Hum Reprod       Date:  1996-09       Impact factor: 6.918

Review 4.  Intra-uterine insemination for unexplained subfertility.

Authors:  Susanne M Veltman-Verhulst; Ben J Cohlen; Edward Hughes; Maas Jan Heineman
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

5.  Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.

Authors:  Mandana Rashidi; Ashraf Aaleyasin; Marzieh Aghahosseini; Shohre Loloi; Abas Kokab; Zahra Najmi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-03-28       Impact factor: 2.435

6.  Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.

Authors:  A Demirol; T Gurgan
Journal:  Hum Reprod       Date:  2006-09-05       Impact factor: 6.918

7.  Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone.

Authors:  R P Dickey; T T Olar; S N Taylor; D N Curole; P H Rye
Journal:  Hum Reprod       Date:  1993-01       Impact factor: 6.918

8.  Efficacy of treatment for unexplained infertility.

Authors:  D S Guzick; M W Sullivan; G D Adamson; M I Cedars; R J Falk; E P Peterson; M P Steinkampf
Journal:  Fertil Steril       Date:  1998-08       Impact factor: 7.329

9.  Outcomes after intrauterine insemination are independent of provider type.

Authors:  Randi H Goldman; Maria Batsis; Michele R Hacker; Irene Souter; John C Petrozza
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

10.  Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.

Authors:  Marco Filicori; Graciela E Cognigni; Patrizia Pocognoli; Cristina Tabarelli; Federica Ferlini; Tiziana Perri; Lodovico Parmegiani
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329

View more
  3 in total

1.  Role of the total progressive motile sperm count (TPMSC) in different infertility factors in IUI: a retrospective cohort study.

Authors:  Haiyan Lin; Yu Li; Songbang Ou; Xuedan Jiao; Wenjun Wang; Peter Humaidan; Qingxue Zhang
Journal:  BMJ Open       Date:  2021-02-05       Impact factor: 2.692

2.  A comprehensive evaluation of pre- and post-processing sperm parameters for predicting successful pregnancy rate following intrauterine insemination with the husband's sperms.

Authors:  Yumei Luo; Mingxing Liu; Shunhong Wu; Mimi Zhang; Jingru Yuan; Yufang Zhong; Qing Li; Xiaofang Sun; Xia Xu; Detu Zhu
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-12       Impact factor: 3.105

3.  Ovarian stimulated cycle: not a better alternative for women without ovulation disorder in intrauterine insemination.

Authors:  Kemei Zhang; Yinjiao Shi; Ensheng Wang; Li Wang; Qingbo Hu; Yibo Dai; Haiyan Xu; Jiaou Zhang; Ping Jin; Xueqin Chen; Jing Shu
Journal:  Oncotarget       Date:  2017-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.